| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hcw Biologics Inc. (HCWB) has 3 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. HCWB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 615.8K | $705.1K | - | |
| Dir | 203.4K | $232.9K | - | |
| CFO | 57.2K | $65.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | Flowers Lee | SVP Of Business Development | Buy | 962 | $26.00 | $25,012.00 | +20.2% | -36.8% | -95.4% | |
| May 8, 2025 | Greene Rick S. | Director | Buy | 962 | $26.00 | $25,012.00 | +87.1% | -36.8% | -95.4% | |
| Sep 14, 2023 | Wong Hing C | Chief Executive Officer | Buy | 1,800 | $2.08 | $3,740.76 | - | -41.8% | -71.4% | |
| Sep 14, 2023 | Winer Gary M53 | Director | Buy | 1,587 | $2.05 | $3,255.91 | +2.5% | -41.8% | -71.4% | |
| Sep 13, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 5,000 | $2.10 | $10,490.00 | +0.9% | -45.5% | -71.7% | |
| Sep 12, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 10,000 | $2.07 | $20,715.00 | +0.9% | -44.8% | -72.9% | |
| Sep 12, 2023 | Winer Gary M53 | Director | Buy | 600 | $2.05 | $1,229.80 | +1.3% | -44.8% | -72.9% | |
| Sep 8, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 10,000 | $1.99 | $19,853.00 | +0.9% | -46.3% | -65.7% | |
| Sep 7, 2023 | Winer Gary M53 | Director | Buy | 463 | $1.78 | $822.85 | +1.6% | -43.6% | -63.9% | |
| Sep 6, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 5,000 | $1.95 | $9,749.00 | +0.9% | -39.7% | -70.4% |